Kos Biotechnology Partners ("Kos"), a global life sciences investment firm bridging the US biopharma ecosystem with Europe, announced the third closing of its inaugural...
Cellino Biotech, Inc., a biotechnology company advancing autonomous, closed biomanufacturing for personalized regenerative medicines, announced the appointment of Chris Gemmiti, Ph.D., as Senior Vice...
